Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
10/1996
10/30/1996EP0739206A1 Composition for drug delivery comprising nicotine or a derivative thereof and starch microspheres and method for the manufacturing thereof
10/30/1996EP0739199A1 Estradiol penetration intensifier for transdermal administration
10/30/1996EP0739197A1 Preserved ophthalmic drug compositions containing polymeric quaternary ammonium compounds
10/30/1996EP0479909B1 Bispecific reagents for aids therapy
10/30/1996EP0271551B1 Acid decrystallization of higly cristalline chitosan or partially deacylated chitin
10/30/1996CN1134672A Inclusion complexes of beta-cyclodextrin with flurbiprofen, ketoprofen and naproxen
10/30/1996CN1134666A Multiple unit tableted dosage form I
10/30/1996CN1134663A New emulsion formulation
10/30/1996CN1134662A Thermally-gelling ophthalmic drug delivery vehicles containing cellulose ethers
10/30/1996CN1033143C Radiopharmaceutical formulations, their method of administration and process of preparation
10/29/1996US5569720 Water soluble; antitumor agents
10/29/1996US5569530 X-rays
10/29/1996US5569465 Aqueous cosmetic or dermo-pharmaceutical composition containing in suspension hydrated spheroids of a hydrophilic lipidic substance
10/29/1996US5569450 Aerosol formulation containing an ester-, amide-, or mercaptoester-derived dispersing aid
10/29/1996US5569449 Biotolerable matrix in association with fluorinated gas, stabilized by presence of cross-linking groups attached to matrix
10/29/1996US5569448 Sulfated nonionic block copolymer surfactants as stabilizer coatings for nanoparticle compositions
10/29/1996CA2175115A1 Porphyrin metal complex-albumin inclusion compound and oxygen carrier composition comprising the same
10/24/1996WO1996033273A1 Botulinum toxin derivatives able to modify peripheral sensory afferent functions
10/24/1996WO1996033233A1 Heterotelechelic block copolymers and process for producing the same
10/24/1996WO1996032965A1 Cd45rb binding compounds for the prevention of transplant rejection
10/24/1996WO1996032964A1 Therapeutic composition comprising an antigen or an in vivo generator for generating a compound comprising an amino acid sequence
10/24/1996WO1996032951A1 Controlled release of miotic and mydriatic drugs in the anterior chamber
10/24/1996WO1996032950A1 Complexing urushiols
10/24/1996WO1996032941A1 Pranoprofen eyedrops containing organic amine
10/24/1996WO1996032933A1 External preparations for treating dermatoses
10/24/1996WO1996032931A2 Composite with sodium starch glycolate as a support material and products thereof
10/24/1996WO1996032841A1 Novel therapeutic binding molecule complexes
10/24/1996CA2218691A1 Novel therapeutic binding molecule complexes
10/24/1996CA2218495A1 Heterotelechelic block copolymer and a method for the production thereof
10/24/1996CA2218486A1 Composite with sodium starch glycolate as a support material and products thereof
10/24/1996CA2214083A1 Complexing urushiols
10/24/1996CA2193742A1 External preparations for treating dermatoses
10/23/1996EP0738327A1 Host-vector system for use in gene therapy
10/23/1996EP0738252A1 Polyol composition produced by co-spray-drying
10/23/1996EP0738155A1 Modular design and synthesis of oxazolone-derived molecules
10/23/1996EP0738141A1 Sucrose ester c-20 to c-28 alcohol formulations
10/23/1996EP0589981B1 Oral-administration forms of a medicament containing pantoprazol
10/23/1996EP0576643B1 Controlled release oxycodone compositions
10/23/1996EP0477339B1 Hydroxyapatite-antigen conjugates and methods for generating a poly-ig immune response
10/23/1996CN1134109A Chemically-defined non-polymeric valency plateform molecules and conjugates thereof
10/23/1996CN1134107A Pharmaceutical composition to enhance tissue healing and regeneration and application kit comprising it
10/23/1996CN1133739A Medical powdered rubber
10/23/1996CN1133722A Process for preparing exterior-use traditional Chinese medicine preparation for treating dysmenorrhea by ear acupoints and preparation thereby
10/22/1996US5567859 Polyoxypropylene/polyoxyethylene copolymers with improved biological activity
10/22/1996US5567690 Carboxymethylmannoglucans and derivatives thereof
10/22/1996US5567685 Water-Soluble polyene conjugate
10/22/1996US5567677 Protein formulation comprising growth hormone
10/22/1996US5567592 Identifying compounds useful for increasing bioavailability of drug in mammal
10/22/1996US5567441 Sustained release pellets comprising multilayer polymeric membrane
10/22/1996US5567440 Methods for modifying cell contact with a surface
10/22/1996US5567437 Effervescent pharmaceutical composition containing ibuprofen and its method of preparation
10/22/1996US5567435 Mixing active material with a solution of polymerizable macromer comprising degradable region and free radical polymerizable end groups
10/22/1996US5567434 Dissolving compound and lipid in aprotic sovent, extruding into aqueous solution
10/22/1996US5567426 Cosmetic compositon in the form of a gelled triple water/silicone oil/water emulsion
10/22/1996US5567425 Plant extracts
10/22/1996US5567422 Azlactone activated polyalkylene oxides conjugated to biologically active nucleophiles
10/22/1996US5567417 Method for inhibiting angiogenesis using heparinase
10/22/1996US5567416 Slow-volatilizing terpenoid composition
10/22/1996US5567414 Image contrast agent
10/22/1996US5567412 Microbubble generating carbohydrate particles mixed with amphiphilic organic acid; ultrasonic or magnetic resonance imaging
10/22/1996CA2021767C Method for preparing a pharmaceutical composition in the form of microparticles
10/22/1996CA1338678C Hydrophilic polyurethanes of improved strength
10/17/1996WO1996032494A1 Fusion protein delivery system and uses thereof
10/17/1996WO1996032434A1 Polyethylene oxides having saccharide residue at one end and different functional group at another end, and process for producing the same
10/17/1996WO1996032419A1 Biodegradable polyacetal polymers and formation and use
10/17/1996WO1996032416A1 Novel anti-aids immunotoxins
10/17/1996WO1996032138A1 Methods for treating respiratory disease
10/17/1996WO1996032137A2 Methods of inducing immune tolerance using immunotoxins
10/17/1996WO1996032136A1 Polysaccharide-bound nitric oxide-nucleophile adducts
10/17/1996WO1996032135A1 Pharmaceutical composition
10/17/1996WO1996032134A2 Conjugate of an active agent, a polyether and possibly a native protein regarded as acceptable by the body
10/17/1996WO1996032133A2 Conjugate for treating inflammatory, infectious and/or skin diseases
10/17/1996WO1996032118A1 Use of nitric oxide-releasing agents to treat impotency
10/17/1996WO1996032116A1 Compositions and methods for nucleic acid delivery to the lung
10/17/1996WO1996032113A1 Novel composition stimulating the cerebral activity and based on alcaloids having an eburnamenine nucleus, and preparation methods
10/17/1996WO1996032102A1 Use of a cationic amphipathic compound as a transfection agent, vaccine additive or drug
10/17/1996WO1996032096A1 Powdered pharmaceutical formulations having improved dispersibility
10/17/1996WO1996032090A1 Dispersible particulate system for desensitizing teeth
10/17/1996WO1996032089A1 LOW pH SKIN-TREATMENT COMPOSITION
10/17/1996WO1996022371A3 C-C CHEMOKINE RECEPTOR 3: CKP-3 OR Eos-L2
10/17/1996WO1996015809A3 Process for the preparation of a pharmacologically active chemical combination
10/17/1996DE19514088A1 Konjugat zur Behandlung von Entzünduns-, Infektions- und/oder Hauterkrankungen A conjugate for the treatment of Entzünduns-, infectious and / or skin diseases
10/17/1996DE19514087A1 Konjugat aus einem Wirkstoff, einem Polyether und ggfs. einem nicht als körperfremd angesehenen, nativen Protein Conjugate of an active ingredient, a polyether and, if necessary, a not as foreign prestigious, native protein
10/17/1996CA2467462A1 Metered dose inhaler for salmeterol
10/17/1996CA2393381A1 Genes encoding lymphocyte interferon regulatory factor (lsirf) polypeptides
10/17/1996CA2218140A1 Polyoxyethylene having a sugar on one end and a different functional group on the other end, and a method for the production thereof
10/17/1996CA2217863A1 Use of nitric oxide-releasing agents to treat impotency
10/17/1996CA2217861A1 Dispersible particulate system for desensitizing teeth
10/17/1996CA2216210A1 Novel anti-aids immunotoxins
10/17/1996CA2192597A1 Use of a cationic amphipathic compound as a transfection agent, vaccine additive or drug
10/16/1996EP0737750A2 Expression of exogenous polynucleotide sequences in a vertebrate
10/16/1996EP0737703A2 Hydrogel-forming , self-solvating absorbable polyester copolymers, and methods for use therefor
10/16/1996EP0737508A1 Use of hydrofluorocarbon compound in an emulsion, emulsion and composition containing the same
10/16/1996EP0737472A1 Single-shot vaccine formulation
10/16/1996EP0737311A1 Diagnostic, prognostic, and therapeutic methods for solid non-lymphoid tumors and their metastases
10/16/1996EP0737201A1 Backbone modified oligonucleotide analogs and solid phase synthesis thereof
10/16/1996EP0737097A1 High internal phase water/oil emulsions and water/oil/water emulsions
10/16/1996EP0737077A1 Hepatocyte-targeted drug conjugates
10/16/1996EP0737066A1 Transdermal device containing polyvinylpyrrolidone as solubility enhancer
10/16/1996EP0737062A1 Water-in-oil lotion containing a corticosteroid
1 ... 1517 1518 1519 1520 1521 1522 1523 1524 1525 1526 1527 1528 1529 1530 1531 1532 1533 1534 1535 1536 1537 ... 1712